New 5-HT6 receptor ligands from the group of sulfonamide derivatives of cyclic arylguanidines in the treatment of glioblastoma multiforme.

2020/37/N/NZ7/02120

Keywords

Descriptors

  • NZ7_014: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Politechnika Krakowska im. Tadeusza Kościuszki, Wydział Inżynierii i Technologii Chemicznej

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Przemysław Patryk Zaręba

Number of co-investigators in the project: 3

Call

PRELUDIUM 19 – announced on 2020-03-16

Amount awarded
209 880 PLN
Project start date
2021-03-26
Project end date
2024-03-25
Project duration
36 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. Eco-friendly methods of synthesis and preliminary biological evaluation of sulfonamide derivatives of cyclic arylguanidines

    Authors:
    Przemysław Zaręba, Anna K. Drabczyk, Artur Wnorowski, Edyta Pindelska, Gniewomir Latacz, Jolanta Jaśkowska
    Academic press:
    Ultrasonics Sonochemistry (year: 2022, volume: 90, pages: 106165), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ultsonch.2022.106165 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski